Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

ALLO Allogene Therapeutics Inc.

交易中 04-21 13:17:31 EDT

1.47

+0.02

+1.12%

最高1.49	最低1.39	成交量87.73万
今开1.41	昨收1.45	日振幅6.90%
总市值3.19亿	流通市值2.29亿	总股本2.17亿
成交额126.41万	换手率0.56%	流通股本1.56亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

{"stockData":{"symbol":"ALLO","market":"US","secType":"STK","nameCN":"Allogene Therapeutics Inc.","latestPrice":1.4663,"timestamp":1745255842456,"preClose":1.45,"halted":0,"volume":877328,"delay":0,"floatShares":156266641,"shares":217264738,"eps":-1.32225,"marketStatus":"交易中","change":0.0163,"latestTime":"04-21 13:17:31 EDT","open":1.41,"high":1.49,"low":1.39,"amount":1264059.7972992,"amplitude":0.068966,"askPrice":1.47,"askSize":1094,"bidPrice":1.46,"bidSize":6534,"shortable":3,"etf":0,"ttmEps":-1.32225,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1745265600000},"marketStatusCode":2,"adr":0,"adrRate":0,"listingDate":1539230400000,"exchange":"NASDAQ","adjPreClose":1.45,"preHourTrading":{"tag":"盘前","latestPrice":1.41,"preClose":1.45,"latestTime":"09:27 EDT","volume":699,"amount":1006.4898903,"timestamp":1745242043806},"postHourTrading":{"tag":"盘后","latestPrice":1.46,"preClose":1.45,"latestTime":"19:58 EDT","volume":17501,"amount":25381.0038,"timestamp":1744934332667},"volumeRatio":0.753368,"impliedVol":0.1968,"impliedVolPercentile":0.056},"requestUrl":"/m/hq/s/ALLO/tweets","defaultTab":"tweets","newsList":[{"id":"2528532724","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.01%","url":"https://stock-news.laohu8.com/highlight/detail?id=2528532724","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2528532724?lang=zh_cn&edition=full","pubTime":"2025-04-18 01:40","pubTimestamp":1744911608,"startTime":"0","endTime":"0","summary":"北京时间2025年04月18日01时40分，Allogene Therapeutics, Inc.股票出现波动，股价大幅上涨5.01%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.66%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc 是一家临床阶段的生物技术公司，专门从事免疫肿瘤学，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418014008973b8620&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250418014008973b8620&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALLO","LENZ","BK4505","BK4139"],"gpt_icon":0},{"id":"2526643479","title":"Allogene Therapeutics, Inc.盘中异动 临近收盘大幅拉升5.11%报1.44美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2526643479","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2526643479?lang=zh_cn&edition=full","pubTime":"2025-04-12 03:47","pubTimestamp":1744400841,"startTime":"0","endTime":"0","summary":"北京时间2025年04月12日03时47分，Allogene Therapeutics, Inc.股票出现异动，股价快速上涨5.11%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.88%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc 是一家临床阶段的生物技术公司，专门从事免疫肿瘤学，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体 T 细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412034723a456802b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250412034723a456802b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","ALLO","BK4139","LENZ","BK4505"],"gpt_icon":0},{"id":"2518320385","title":"Allogene Therapeutics, Inc.盘中异动 股价大跌5.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2518320385","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2518320385?lang=zh_cn&edition=full","pubTime":"2025-03-11 01:06","pubTimestamp":1741626373,"startTime":"0","endTime":"0","summary":"北京时间2025年03月11日01时06分，Allogene Therapeutics, Inc.股票出现异动，股价快速下挫5.05%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.59%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110106139640612d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202503110106139640612d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2517192780","title":"Allogene Therapeutics, Inc.盘中异动 急速拉升5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2517192780","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2517192780?lang=zh_cn&edition=full","pubTime":"2025-03-07 03:48","pubTimestamp":1741290532,"startTime":"0","endTime":"0","summary":"北京时间2025年03月07日03时48分，Allogene Therapeutics, Inc.股票出现异动，股价大幅上涨5.18%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.56%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034853a262db6c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250307034853a262db6c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","LENZ","ALLO"],"gpt_icon":0},{"id":"2516709766","title":"Allogene Therapeutics, Inc.盘中异动 早盘大幅下跌5.56%报1.70美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2516709766","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2516709766?lang=zh_cn&edition=full","pubTime":"2025-03-04 23:00","pubTimestamp":1741100428,"startTime":"0","endTime":"0","summary":"北京时间2025年03月04日23时00分，Allogene Therapeutics, Inc.股票出现波动，股价快速跳水5.56%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.17%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030423002996394d5b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025030423002996394d5b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","BK4139","ALLO","LENZ"],"gpt_icon":0},{"id":"2514933209","title":"Allogene Therapeutics, Inc.盘中异动 下午盘股价大跌5.15%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514933209","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514933209?lang=zh_cn&edition=full","pubTime":"2025-02-28 04:29","pubTimestamp":1740688154,"startTime":"0","endTime":"0","summary":"北京时间2025年02月28日04时29分，Allogene Therapeutics, Inc.股票出现波动，股价快速跳水5.15%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.38%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280429149632f210&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502280429149632f210&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","LENZ","ALLO","BK4505"],"gpt_icon":0},{"id":"2514851245","title":"Allogene Therapeutics, Inc.盘中异动 大幅拉升5.04%报2.09美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514851245","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514851245?lang=zh_cn&edition=full","pubTime":"2025-02-26 23:05","pubTimestamp":1740582333,"startTime":"0","endTime":"0","summary":"北京时间2025年02月26日23时05分，Allogene Therapeutics, Inc.股票出现波动，股价快速拉升5.04%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262305339893b1a0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502262305339893b1a0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2514090392","title":"Allogene Therapeutics, Inc.盘中异动 股价大跌5.11%报2.03美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2514090392","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2514090392?lang=zh_cn&edition=full","pubTime":"2025-02-25 22:36","pubTimestamp":1740494211,"startTime":"0","endTime":"0","summary":"北京时间2025年02月25日22时36分，Allogene Therapeutics, Inc.股票出现异动，股价大幅下挫5.11%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.25%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223652962ff3dc&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250225223652962ff3dc&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","ALLO","BK4505","BK4139"],"gpt_icon":0},{"id":"2513783957","title":"Allogene Therapeutics, Inc.盘中异动 急速下挫5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513783957","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513783957?lang=zh_cn&edition=full","pubTime":"2025-02-24 23:04","pubTimestamp":1740409478,"startTime":"0","endTime":"0","summary":"北京时间2025年02月24日23时04分，Allogene Therapeutics, Inc.股票出现波动，股价快速下挫5.07%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.37%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242304389890fe06&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502242304389890fe06&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4505","ALLO","LENZ"],"gpt_icon":0},{"id":"2513968372","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.10%","url":"https://stock-news.laohu8.com/highlight/detail?id=2513968372","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2513968372?lang=zh_cn&edition=full","pubTime":"2025-02-21 22:31","pubTimestamp":1740148285,"startTime":"0","endTime":"0","summary":"北京时间2025年02月21日22时31分，Allogene Therapeutics, Inc.股票出现波动，股价大幅拉升5.10%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.33%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223126988dddfe&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250221223126988dddfe&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","BK4139","LENZ","BK4505"],"gpt_icon":0},{"id":"2512488265","title":"Allogene Therapeutics, Inc.盘中异动 大幅上涨12.68%","url":"https://stock-news.laohu8.com/highlight/detail?id=2512488265","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512488265?lang=zh_cn&edition=full","pubTime":"2025-02-19 22:31","pubTimestamp":1739975468,"startTime":"0","endTime":"0","summary":"北京时间2025年02月19日22时31分，Allogene Therapeutics, Inc.股票出现波动，股价急速拉升12.68%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.15%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223108a24bf90d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250219223108a24bf90d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2512166483","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨6.86%报2.18美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2512166483","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2512166483?lang=zh_cn&edition=full","pubTime":"2025-02-18 22:31","pubTimestamp":1739889064,"startTime":"0","endTime":"0","summary":"北京时间2025年02月18日22时31分，Allogene Therapeutics, Inc.股票出现异动，股价快速上涨6.86%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.23%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223104a24aac42&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250218223104a24aac42&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4505","LENZ","ALLO","BK4139"],"gpt_icon":0},{"id":"2511992696","title":"Allogene Therapeutics, Inc.盘中异动 早盘大幅上涨14.89%","url":"https://stock-news.laohu8.com/highlight/detail?id=2511992696","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2511992696?lang=zh_cn&edition=full","pubTime":"2025-02-14 22:31","pubTimestamp":1739543518,"startTime":"0","endTime":"0","summary":"北京时间2025年02月14日22时31分，Allogene Therapeutics, Inc.股票出现异动，股价快速上涨14.89%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.18%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223159a24600ec&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250214223159a24600ec&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","BK4505","LENZ","BK4139"],"gpt_icon":0},{"id":"2510334882","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大跌5.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2510334882","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2510334882?lang=zh_cn&edition=full","pubTime":"2025-02-12 00:14","pubTimestamp":1739290440,"startTime":"0","endTime":"0","summary":"北京时间2025年02月12日00时14分，Allogene Therapeutics, Inc.股票出现波动，股价快速跳水5.07%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为1.53%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120014009881cf12&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502120014009881cf12&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","BK4139","LENZ","BK4505"],"gpt_icon":0},{"id":"2509472746","title":"Allogene Therapeutics, Inc.盘中异动 下午盘快速下跌5.00%报1.52美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2509472746","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509472746?lang=zh_cn&edition=full","pubTime":"2025-02-08 02:28","pubTimestamp":1738952911,"startTime":"0","endTime":"0","summary":"北京时间2025年02月08日02时28分，Allogene Therapeutics, Inc.股票出现波动，股价急速下挫5.00%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.55%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022831987dd615&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250208022831987dd615&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4505","ALLO","BK4139"],"gpt_icon":0},{"id":"2509452280","title":"Allogene Therapeutics, Inc.盘中异动 大幅上涨5.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2509452280","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2509452280?lang=zh_cn&edition=full","pubTime":"2025-02-05 23:14","pubTimestamp":1738768473,"startTime":"0","endTime":"0","summary":"北京时间2025年02月05日23时14分，Allogene Therapeutics, Inc.股票出现波动，股价急速上涨5.25%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为1.15%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231433987b83dd&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250205231433987b83dd&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLO","BK4505","LENZ"],"gpt_icon":0},{"id":"2508141292","title":"Allogene Therapeutics, Inc.盘中异动 股价大跌5.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2508141292","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508141292?lang=zh_cn&edition=full","pubTime":"2025-02-03 22:45","pubTimestamp":1738593921,"startTime":"0","endTime":"0","summary":"北京时间2025年02月03日22时45分，Allogene Therapeutics, Inc.股票出现异动，股价大幅跳水5.00%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.35%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032245219616fe3b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202502032245219616fe3b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","LENZ","BK4139","BK4505"],"gpt_icon":0},{"id":"2508996017","title":"Allogene Therapeutics, Inc.盘中异动 股价大跌5.21%报1.82美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2508996017","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2508996017?lang=zh_cn&edition=full","pubTime":"2025-02-01 02:54","pubTimestamp":1738349688,"startTime":"0","endTime":"0","summary":"北京时间2025年02月01日02时54分，Allogene Therapeutics, Inc.股票出现异动，股价快速跳水5.21%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.63%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201025448abbe6896&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250201025448abbe6896&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","ALLO","BK4505","LENZ"],"gpt_icon":0},{"id":"2507977674","title":"Allogene Therapeutics, Inc.盘中异动 股价大涨5.16%报1.94美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2507977674","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2507977674?lang=zh_cn&edition=full","pubTime":"2025-01-31 02:50","pubTimestamp":1738263014,"startTime":"0","endTime":"0","summary":"北京时间2025年01月31日02时50分，Allogene Therapeutics, Inc.股票出现波动，股价快速上涨5.16%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.35%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131025014a2347ffb&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250131025014a2347ffb&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","BK4505","ALLO"],"gpt_icon":0},{"id":"2506117195","title":"Allogene Therapeutics, Inc.盘中异动 早盘股价大涨5.18%","url":"https://stock-news.laohu8.com/highlight/detail?id=2506117195","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2506117195?lang=zh_cn&edition=full","pubTime":"2025-01-28 22:31","pubTimestamp":1738074688,"startTime":"0","endTime":"0","summary":"北京时间2025年01月28日22时31分，Allogene Therapeutics, Inc.股票出现波动，股价快速拉升5.18%。Allogene Therapeutics, Inc.股票所在的生物技术行业中，整体涨幅为0.01%。Allogene Therapeutics, Inc.公司简介：Allogene Therapeutics Inc是一家专门从事免疫肿瘤学的临床阶段生物技术公司，专注于开发用于癌症和自身免疫性疾病的基因工程同种异体T细胞产品。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282231289612f453&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN202501282231289612f453&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["ALLO","BK4505","LENZ","BK4139"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.allogene.com","stockEarnings":[{"period":"1week","weight":0.0584},{"period":"1month","weight":-0.142},{"period":"3month","weight":-0.2033},{"period":"6month","weight":-0.4894},{"period":"1year","weight":-0.5869},{"period":"ytd","weight":-0.3192}],"compareEarnings":[{"period":"1week","weight":0.0035},{"period":"1month","weight":-0.0617},{"period":"3month","weight":-0.1191},{"period":"6month","weight":-0.0995},{"period":"1year","weight":0.0517},{"period":"ytd","weight":-0.1018}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Allogene Therapeutics, Inc.于2017年11月30日在特拉华州成立，总部位于加利福尼亚州南旧金山。该公司是一家临床阶段免疫肿瘤学公司，开创了用于治疗癌症的基因工程异体T细胞疗法的开发和商业化。公司正在开发一种现成的T细胞候选产品系列，旨在靶向和杀死癌细胞。Allogene Therapeutics, Inc.工程改造的T细胞是同种异体的，这意味着来自健康供体，用于任何患者，而不是来自患者的个体患者，如自体T细胞的情况。","yearOnYearQuotes":[{"month":1,"riseRate":0.571429,"avgChangeRate":0.039071},{"month":2,"riseRate":0.714286,"avgChangeRate":0.055444},{"month":3,"riseRate":0.142857,"avgChangeRate":-0.131149},{"month":4,"riseRate":0.428571,"avgChangeRate":0.003555},{"month":5,"riseRate":0.166667,"avgChangeRate":0.032626},{"month":6,"riseRate":0.5,"avgChangeRate":0.040631},{"month":7,"riseRate":0.5,"avgChangeRate":0.041827},{"month":8,"riseRate":0.333333,"avgChangeRate":-0.054633},{"month":9,"riseRate":0.666667,"avgChangeRate":-0.032739},{"month":10,"riseRate":0.166667,"avgChangeRate":-0.102868},{"month":11,"riseRate":0.285714,"avgChangeRate":0.004346},{"month":12,"riseRate":0.142857,"avgChangeRate":-0.104939}],"exchange":"NASDAQ","name":"Allogene Therapeutics Inc.","nameEN":"Allogene Therapeutics Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.33.2","shortVersion":"4.33.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Allogene Therapeutics Inc.,ALLO,Allogene Therapeutics Inc.股票,Allogene Therapeutics Inc.股票老虎,Allogene Therapeutics Inc.股票老虎国际,Allogene Therapeutics Inc.行情,Allogene Therapeutics Inc.股票行情,Allogene Therapeutics Inc.股价,Allogene Therapeutics Inc.股市,Allogene Therapeutics Inc.股票价格,Allogene Therapeutics Inc.股票交易,Allogene Therapeutics Inc.股票购买,Allogene Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Allogene Therapeutics Inc.(ALLO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Allogene Therapeutics Inc.(ALLO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}